Efficacy of N‐acetylcysteine in the prevention of alcohol relapse‐like drinking: Study in long‐term ethanol‐experienced male rats. Issue 2 (16th October 2020)

• Record Type: Journal Article
• Authors: Cano‐Cebrián, María José; Fernández‐Rodríguez, Sandra; Hipólito, Lucia; Granero, Luis; Polache, Ana; Zornoza, Teodoro
• Is Part Of: Journal of neuroscience research. Volume 99:Issue 2(2021)
• Page Start: 638
• Page End: 648
• Publication Date: 2020-10-16
• Subjects: alcohol deprivation effect -- alcohol use disorders -- cue‐induced relapse -- ethanol relapse prevention -- glutamate neurotransmission -- N‐acetylcysteine -- pharmacotherapy; Neurobiology -- Periodicals; 612
• DOI: 10.1002/jnr.24736
• Languages: English
• ISSNs: 0360-4012

Abstract

Abstract: Alcohol use disorders are chronic and highly relapsing disorders, thus alcoholic patients have a high rate of recidivism for drug use even after long periods of abstinence. The literature points to the potential usefulness of N‐acetylcysteine (NAC) in the management of several substance use disorders probably due to its capacity to restore brain homeostasis of the glutamate system disrupted in addiction. However, there is little evidence in the case of alcohol. The aim of this study was to explore the potential anti‐relapse efficacy of NAC using the alcohol deprivation effect (ADE) model in long‐term experienced rats. Two experiments were performed in male Wistar rats to: (a) test the efficacy of NAC to prevent relapse and (b) discriminate the best administration schedule (intermittent vs. continuous) for NAC. In the first experiment, animals were implanted with mini‐osmotic pumps delivering 0 or 1 mg/hr NAC during 14 days. In a second experiment, rats received 0, 60, or 100 mg/kg once daily by subcutaneous injection. The efficacy to prevent ADE was evaluated in both experiments. NAC subcutaneously administered, either by continuous infusion or by intermittent injections regimen, is able to block the ADE. The best results were obtained after using 60 mg/kg NAC dose. Our findings support the hypothesis that NAC may represent a valuable therapy in the management of alcohol relapse. Abstract : In this research, the potential anti‐relapse efficacy of N‐acetylcysteine (NAC), using the alcohol deprivation effect (ADE) model in long‐term experienced male Wistar rats, has been explored. Two different experiments were performed in order to: (a) test the efficacy of NAC to prevent relapse and (b) discriminate the best administration schedule (intermittent vs. continuous) for the drug. NAC subcutaneously administered, either by continuous infusion or by intermittent injections regimen, was able to block the ADE. The best results were obtained after using 60 mg/kg NAC dose under an intermittent regimen.